Landiolol, an intravenous β1‐selective blocker, is useful for dissociating a fusion of atrial activation via accessory pathway and atrioventricular node.

Autor:	Kinjo, Takahiko, Kimura, Masaomi, Kaname, Noriyoshi, Horiuchi, Daisuke, Itoh, Taihei, Ishida, Yuji, Nishizaki, Kimitaka, Toyama, Yuichi, Sasaki, Shingo, Tomita, Hirofumi
Předmět:	CLINICAL trials RESEARCH methodology ATRIAL fibrillation CATHETER ablation FISHER exact test ADRENERGIC beta blockers ELECTROPHYSIOLOGY TREATMENT effectiveness HEART atrium TACHYCARDIA DESCRIPTIVE statistics DATA analysis software RECEIVER operating characteristic curves HIS bundle LONGITUDINAL method
Zdroj:	Journal of Arrhythmia; Dec2023, Vol. 39 Issue 6, p937-946, 10p
Abstrakt:	Introduction: During ventricular pacing, a fusion of atrial activation may occur owing to the simultaneous retrograde conduction of the atrioventricular (AV) node and accessory pathway (AP), potentially leading to an inaccurate mapping of the atrial AP insertion site. Objective: We tested the hypothesis that landiolol, an ultra‐short‐acting intravenous β1‐blocker, could dissociate a fusion of atrial activation. Methods: We conducted a prospective before‐and‐after study to investigate the effect of landiolol on retrograde conduction via the AV node and AP. We enrolled 21 consecutive patients with orthodromic AV reciprocating tachycardia who underwent electrophysiological studies at our hospital between January 1, 2018, and August 31, 2020. Results: Six patients exhibited a fusion of atrial activation. After landiolol administration (10 μg/kg/min), the effective refractory period was unchanged in AP (280 [240–290] ms vs. 280 [245–295] ms, p =.91), whereas that of the AV node was prolonged (275 [215–380] ms vs. 332 [278–445] ms, p =.03). The Wenckebach pacing rate via retrograde AV node decreased after landiolol administration (180 [140–200] beats per minute [bpm] vs. 140 [120–180] bpm, p =.02). Thus, landiolol decreased the minimum ventricular pacing rate required to dissociate a fusion of atrial activation (180 [160–200] bpm vs. 140 [128–155] bpm, p =.007). Radiofrequency catheter ablation under landiolol administration successfully eliminated AP in all patients during ventricular pacing without complications or recurrence. Conclusion: Landiolol inhibited the AV node without affecting the AP and helped dissociate a fusion of atrial activation at a lower ventricular pacing rate. [ABSTRACT FROM AUTHOR]
Databáze:	Supplemental Index
Externí odkaz:	Zobrazit plný text záznamu Plný text